News The FDA has approved Spravato nasal spray to treat major depressive disorder March 6, 2019 Kelly Tyko, USA TODAY Comments Off on The FDA has approved Spravato nasal spray to treat major depressive disorder Spravato nasal spray, also known as esketamine, can now be used to treat depression in adults with treatment-resistant depression.